Lincoln Pharmaceuticals (BOM:531633) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531633 Lincoln Pharmaceuticals Ltd BOM:531633
80 GF Score
Price ₹598.65
GF Value ₹713.39
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lincoln Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

BOM:531633
80GF Score
Lincoln Pharmaceuticals Ltd BOM:531633
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lincoln Pharmaceuticals (BOM:531633) Overvalued in 2026?

Based on GuruFocus' analysis, Lincoln Pharmaceuticals stock appears to be undervalued. The current stock price of ₹598.65 is trading 16.1% below its estimated GF Value™ of ₹713.39. GuruFocus considers Lincoln Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BOM:531633:

  • FFO:
  • GF Value™: ₹713.39 vs. price of ₹598.65 (16.1% below fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the BOM:531633 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lincoln Pharmaceuticals Business Description

Other Exchanges LINCOLN:India
Address Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
80GF Score

Get the complete analysis for BOM:531633

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹598.65
Price
₹713.39
GF Value